Table 1. Association between rs6904029 and risk of chronic lymphocytic leukemia.
GWAS | Replication | Combined* | ||||||
---|---|---|---|---|---|---|---|---|
Genotype | Cases | Controls | ORa (95% CIb) | Cases | Controls | OR (95% CI) | OR (95% CI) | Phet (I2) |
AA | 67 | 213 | 1.94 (1.40-2.66) | 100 | 113 | 1.52 (1.12-2.07) | 1.71 (1.37-2.13) | 0.28 (13.7%) |
AG | 212 | 1,109 | 1.18 (0.96-1.45) | 389 | 613 | 1.09 (0.91-1.31) | 1.13 (0.99-1.29) | 0.57 (0.0%) |
GG | 223 | 1,375 | - | 408 | 703 | - | - | - |
Total | 502 | 2,697 | 1.32 (1.14-1.52) per allele Ptrend=1.38x10-4 |
897 | 1,429 | 1.18 (1.04-1.34) per allele Ptrend=0.01 |
1.24 (1.13-1.36) Ptrend=1.00x10-5 |
0.25 (25.5%) |
Odds Ratio.
95% Confidence Interval.
Meta-analysis under fixed effects model. Phet, P-value for heterogeneity between studies determined from Cochran’s Q statistic. I2, proportion of the total variation due to heterogeneity calculated; I2 values ≥75% are considered characteristic of large heterogeneity.